Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Blood Pressure. Supplement|June 15, 2007
The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapySteven G Chrysant, Daniel H Sugimoto, Marty Lefkowitz, et al.Current Medical Research and Opinion|November 11, 2010
Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertensionSteven G Chrysant, Alexander V Murray, Uta C Hoppe, et al.Current Medical Research and Opinion|March 1, 2008
Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysisSteven G Chrysant, Alexander V Murray, Uta C Hoppe, et al.Cardiovascular Diabetology|November 1, 2012
Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY studyDean J Kereiakes, Steven G Chrysant, Joseph L Izzo, et al.Ethnicity & Disease|March 14, 2014
Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY studyAndrew J Lewin, Dean J Kereiakes, Steven G Chrysant, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|May 7, 2011
Blood pressure effects of naproxcinod in hypertensive patientsRaymond Townsend, Neville Bittar, Jeffrey Rosen, et al.Journal of the American Society of Hypertension : JASH|October 28, 2011
Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY studySteven G Chrysant, Joseph L Izzo, Dean J Kereiakes, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 18, 2012
Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group studySteven G Chrysant, Thomas Littlejohn, Joseph L Izzo, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|March 1, 2012
Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertensionDean J Kereiakes, Steven G Chrysant, Joseph L Izzo, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2011
24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudyJoseph L Izzo, Steven G Chrysant, Dean J Kereiakes, et al.Pageof 12